Weili Gu

机构：Peking University · ORCID：0000-0002-0448-110X

发表论文 116 篇 · 总被引 1139 次 · h-index 17

代表论文

• Mitigation of polystyrene microplastic-induced hepatotoxicity in human hepatobiliary organoids through bile extraction (2024 · Ecotoxicology and Environmental Safety · 被引 23)
• Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study (2024 · BMC Medicine · 被引 18)
• 5MO: First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRASG12C-mutated non-small cell lung cancer (NSCLC) and PD-L1 ≥50% from the phase II portion of KRYSTAL-7 (2025 · Journal of Thoracic Oncology · 被引 9)
• LBA7 Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05 (2024 · Annals of Oncology · 被引 9)
• Losartan alleviates renal fibrosis by inhibiting the biomechanical stress-induced epithelial-mesenchymal transition of renal epithelial cells (2023 · Archives of Biochemistry and Biophysics · 被引 9)
• Low-Molecular-Weight Heparin Plus Insulin in Hypertriglyceridemic Acute Pancreatitis (2025 · JAMA Network Open · 被引 6)